|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. BDMP. See Birth Defects Monitoring Program Behavioral changes, subtle, 73-74 Behavioral Risk Factor Surveillance System, 106 Benzene, 19 Beta probabilities, 21 Biologically effective dose. See Dose Biologic markers, 17, 20, 33, 51, 56-58, 62, 81-84. See also Sampling, personal cost of, 81 Biologic Markers in Immunotoxicology,81 Birth defects. See Congenital anomalies Birth Defects Monitoring Program, 105, 108-109, 163-165 Blood samples. See Sampling, personal Bootstrap procedure, 141-142 Breathing zone measurements, 38-39 Breath samples. See Sampling, personal Bronchitis acute, in children, 70 C Cancer Incidence Reporting System (Canada), 123 Cancers, 15, 23, 46, 68-69, 80 endometrial carcinoma, 14 hepatic angiosarcoma, 23 laryngeal, 147 leukemia, 19 mesothelioma, 19 stomach, 14 Carbon monoxide, 39 Cardiac defects, 78 Cardiovascular disease, 6, 15, 18 Case-control studies, 17-19, 115, 148, 176 Case-crossover studies, 148 Case reports, 13 Causality, inferring. See Epidemiology studies Census data, 15-16 Centers for Disease Control and Prevention, 126, 163-164, 168 Central nervous system (CNS) complications. See Neurologic symptomatology CERCLA. See Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA) Chemicals agricultural (See Herbicides; Pesticides) Children, susceptibility of, 85 Chromium, 46 Classification errors. See Misclassification Cleaning products, 39 Clean Water Act, 102 Cleft lip and palate, 164-165 CNS. See Neurologic symptomatology Coefficients of variation, 83 Cohort studies, 17-18, 114, 176. See also Case-cohort studies Complex mixtures. See Chemicals, mixed Comprehensive Environmental Response, Compensation, and Liability Act of 1980, 116 Confidence bounds, 22 Confidentiality issues, 120-123 Confounding factors, 5-6, 15-16, 19, 22, 50, 83, 120, 134, 174 Congenital anomalies, 2, 78-79, 162-163, 167-168 Congenital Malformations Surveillance Report, 168 Consumer products, measuring concentrations of, 38-39 Cox proportional hazard model, 144 Cross-sectional surveys, 19-20, 114 Croup attacks, 71
|
|
|||||||||||||||
